Review of the direct and indirect effects of hyperglycemia on the HPA axis in T2DM and the co-occurrence of depression
Open Access
- 27 February 2024
- journal article
- review article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (1) , e003218
Abstract
Type 2 diabetes mellitus (T2DM) is characterized by persistent hyperglycemia which is further associated with hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. Several studies have shown that HPA axis hyperactivity is heightened in the chronic hyperglycemic state with severe hyperglycemic events more likely to result in a depressive disorder. The HPA axis is also regulated by the immune system. Upon stress, under homeostatic conditions, the immune system is activated via the sympatho-adrenal-medullary axis resulting in an immune response which secretes proinflammatory cytokines. These cytokines aid in the activation of the HPA axis during stress. However, in T2DM, where there is persistent hyperglycemia, the immune system is dysregulated resulting in the elevated concentrations of these cytokines. The HPA axis, already activated by the hyperglycemia, is further activated by the cytokines which all contribute to a diagnosis of depression in patients with T2DM. However, the onset of T2DM is often preceded by pre-diabetes, a reversible state of moderate hyperglycemia and insulin resistance. Complications often seen in T2DM have been reported to begin in the pre-diabetic state. While the current management strategies have been shown to ameliorate the moderate hyperglycemic state and decrease the risk of developing T2DM, research is necessary for clinical studies to profile these direct effects of moderate hyperglycemia in pre-diabetes on the HPA axis and the indirect effects moderate hyperglycemia may have on the HPA axis by investigating the components of the immune system that play a role in regulating this pathway.Keywords
Funding Information
- National Research Fund, South Africa (MND190605442834)
This publication has 91 references indexed in Scilit:
- Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depressionBrain, Behavior, and Immunity, 2017
- Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and TreatmentDrugs, 2015
- Effects of Glucocorticoids in the Immune System2015
- Effects of stress on immune function: the good, the bad, and the beautifulImmunologic Research, 2014
- Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour2014
- Glucocorticoids and endothelial cell barrier functionCell and tissue research, 2013
- Depression and type 2 diabetes: Cortisol pathway implication and investigational needsJournal of Cellular Physiology, 2012
- Biological Basis of Depression in Adults with DiabetesCurrent Diabetes Reports, 2010
- Cytokines and HPA Axis Regulation2003
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001